Nootropic merchant accounts UK

Nootropics straddle two acquirer worlds. Licensed supplement formulations can sometimes be placed with supplement-friendly acquirers, but research-compound nootropics and any cognitive claims push the whole account into high-risk territory, and mainstream processors often decline on category to avoid the ambiguity. Specialist nutraceutical and research-chemical acquirers underwrite nootropics depending on the exact product mix, at elevated rates with a rolling reserve. How you split licensed supplements from research compounds determines the route.

Legal status (UK)

Licensed nootropic supplements are legal under UK food-supplement and Novel Food rules. Research-only nootropic compounds (such as racetams) are a separate research-chemical category and must be labelled not for human consumption. Cognitive and health claims are tightly restricted under the GB Nutrition and Health Claims Register.

Best way to take Nootropic payments (UK)

Our pick

MerchantHQ, specialist Nootropic broker and account team

Mainstream UK acquirers (SumUp, Square, Zettle, Dojo, Worldpay, Barclaycard) decline Nootropic at onboarding or terminate after launch. We hold a specialist panel of UK high-risk acquirers that underwrite it. As a broker we match you to the right one for your licence, volume and processing history, then stay on as your named UK account team for the life of the agreement.

The acquirer pays our commission on signup, so it costs you nothing on top, and we never sell your details on. We disclose the risk classification upfront so the right underwriter is approached from the start.

Get matched to a Nootropic acquirer

High-risk merchants are the most exposed to chargebacks, frozen funds and MATCH/TMF listings, and that is exactly what your MerchantHQ account team handles, for the life of the agreement.

How Nootropic placements work

Nootropic routes to specialist regulated-vertical acquirers matched per application rather than a published list. The right underwriter depends on your licence, volume and sub-category, so we approach it individually. We hold the relationships and disclose your risk classification upfront so the right acquirer is contacted from the start.

Typical pricing

Rate
2.8% to 4.5% blended
Settlement reserve
5% to 12% rolling reserve common

Watch outs

  • Keep licensed supplements and research-only compounds on clearly separated product lines; mixing them complicates underwriting.
  • Cognitive, memory and focus claims must comply with the GB Nutrition and Health Claims Register or be removed.
  • Research-compound nootropics must carry not-for-human-consumption labelling.
  • Subscription billing raises chargeback risk and reserve levels.
OM

Oliver Mackman

Director, MerchantHQ

Oliver leads MerchantHQ's terminal testing and acquirer comparison. With a background in UK commercial finance and merchant payments, he oversees terminal reviews, switching guidance and high-risk vertical mapping.

Last reviewed: 3 June 2026